Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria
| Brand name | PAXIL |
| Generic name | PAROXETINE HYDROCHLORIDE |
| Active ingredient(s) | PAROXETINE HYDROCHLORIDE |
| Distributed by / for | Apotex Corp., Weston, Florida 33326 |
| NDC | 60505-4379-3 |
| Full product label | Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-4379-3 |
| Recalling firm | Apotex Corp. |
| Distribution | US Nationwide. |
| Quantity | 6,972 bottles |
| Recall initiated | 2026-08-13 |
| Report date | 2026-09-02 |
| Recall completed | — |
| Recall number | D-0804-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Weston FL United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗